Skip to main content
Log in

Natural killer cells in carcinomatous pleural effusions

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Effector cells in carcinomatous pleural effusions of patients with primary or secondary lung cancer were examined for natural killer (NK) activity against K562 cells in a 4-h chromium release assay, and for mitogenic responses and lymphocyte subpopulation constitutions. NK activity of lymphocyte-rich mononuclear cells isolated from carcinomatous pleural effusions by centrifugation on a discontinuous gradient of Ficoll-Hypaque was markedly low in seven of 40 patients studied, and absent in the other 33 cases. NK activity of peripheral blood mononuclear cells from the patients was lower than that of cells from normal donors, but always higher than that of effusion cells from the same patients. NK cells in the peripheral blood and in pleural effusions had some characteristics in common, in that they lacked a capacity to bind sheep erythrocytes, were nonadherent to Sephadex G-10 beads and nylon wool, and belonged to large granular lymphocytes. On the other hand, nonmalignant effusions of patients with congestive heart failure had significant NK activity. The effector cells in the effusions included a higher frequency of T cells than those in the peripheral blood of the same patients. Proliferative responses to phytohemagglutinin and concanavalin A of effusion cells were comparable to those of normal blood cells and were higher than those of blood cells from the same patients. The reason for low NK activity and high mitogenic response in carcinomatous pleural effusions is as yet undefined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Catanzara A, Barker AF (1976) Immunocompetence of pleural fluid lymphocytes. Clin Res 24:326A

    Google Scholar 

  2. Domagala W, Emeson, EE, Koss LG (1978) Distribution of T-lymphocytes and B-lymphocytes in peripheral blood and effusions of patients with cancer. J Natl Cancer Inst 61:295

    Google Scholar 

  3. Eremin O, Ashby J, Stephens JP (1978a) Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease. Int J Cancer 21:35

    Google Scholar 

  4. Eremin O, Coombs RRA, Plumb D, Ashby J (1978b) Characterization of the human natural killer (NK) cell in blood and lymphoid organs. Int J Cancer 21:42

    Google Scholar 

  5. Gillespie GY, Hansen CH, Hoskins RG, Russel SW (1977) Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas. J Immunol 111:564

    Google Scholar 

  6. Herberman RB, Holden T (1978) Natural cell-mediated immunity. Adv Cancer Res 27:305

    Google Scholar 

  7. Herberman RB, Nunn ME, Lavrin DH (1975) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16:216

    Google Scholar 

  8. Jondal M, Klein G (1975) Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies. Biomedicine 23:163

    Google Scholar 

  9. Jondal M, Pross H (1975) Surface markers on human B and T lymphocytes. IV. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer 15:596

    Google Scholar 

  10. Kay HD, Bonnard GD, West WH, Herberman RB (1977) A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol 118:2058

    Google Scholar 

  11. Kiessling R, Klein E, Wigzell H (1975) “Natural” cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5:112

    Google Scholar 

  12. Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321

    Google Scholar 

  13. Montovani A, Allavena P, Sessa C, Bolis G, Mangioni C (1980) Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors. Int J Cancer 25:573

    Google Scholar 

  14. Moore K, Moore M (1979) Systemic and in situ natural killer activity in tumor-bearing rats. Br J Cancer 39:636

    Google Scholar 

  15. Pross HF, Baines MG (1976) Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. I. The effect of malignant disease. Int J Cancer 18:261

    Google Scholar 

  16. Russel SW, Gillespie GY, Hansen CB, Cochrane CG (1976) Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression. Int J Cancer 18:331

    Google Scholar 

  17. Takasugi M, Mickey MR, Terasaki PI (1973) Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res 33:2898

    Google Scholar 

  18. Takasugi M, Ramseyer A, Takasugi J (1977) Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res 37:413

    Google Scholar 

  19. Timonen T, Saksela E (1980) Isolation of human NK cells by density gradient centrifugation. J Immunol Methods 36:285

    Google Scholar 

  20. Timonen T, Saksela E, Ranki A, Häyry P (1979) Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. Cell Immunol 48:133

    Google Scholar 

  21. Tötterman TH, Häyry P, Saksela E, Timonen T, Eklund B (1978) Cytological and functional analysis of inflammatory infiltrates in human malignant tumor. II. Functional investigations of the infiltrating inflammatory cells. Eur J Immunol 8:872

    Google Scholar 

  22. Uchida A, Hoshino T (1980a) Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on phytomitogen responsiveness in vitro. Cancer 45:476

    Google Scholar 

  23. Uchida A, Hoshino T (1980b) Clinical studies on cell-mediated immunity in patients with malignant disease. II. Suppressor cells in patients with cancer. Cancer Immunol Immunother 9:153

    Google Scholar 

  24. Uchida A, Hoshino T (1980c) Reduction of suppressor cells in cancer patients treated with OK-432 immunotherapy. Int J Cancer 26:401

    Google Scholar 

  25. Uchida A, Micksche M (to be published) Concanavalin A-inducible suppressor cells in pleural effusions and peripheral blood of cancer patients. Cancer Immunol Immunother

  26. Vose BM, Vánky F, Klein E (1977a) Human tumor-lymphocyte interaction in vitro. V. Comparison of the reactivity of tumor-infiltrating, blood and lymph-node lymphocytes with autologous tumor cells. Int J Cancer 20:895

    Google Scholar 

  27. Vose BM, Vánky F, Argov S, Klein E (1977b) Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes. Eur J Immunol 7:753

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uchida, A., Micksche, M. Natural killer cells in carcinomatous pleural effusions. Cancer Immunol Immunother 11, 131–138 (1981). https://doi.org/10.1007/BF00199264

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199264

Keywords

Navigation